Chetan Seshadri, MD | Allergy and Infectious Diseases

Associate Professor

Department of Medicine, Division of Allergy & Infectious Diseases

Adjunct Professor

Department of Pathology

Affiliate Investigator

Vaccine & Infectious Diseases Division (VIDD), Fred Hutchinson Cancer Research Center

Sites of Practice:

Harborview Medical Center

University of Washington Medical Center

Faculty Information

Biography

Dr. Seshadri's research focuses on the human immune response to Mycobacterium tuberculosis, the bacteria responsible for tuberculosis. By better understanding what factors are responsible for protective immunity, he hopes to contribute to ongoing efforts to develop an effective vaccine. Specifically, his work addresses two questions:

What is the role of T-cells that respond to lipids and small molecules produced by bacteria?
Why do some people fail to convert their tuberculin skin tests despite frequent and close contact with tuberculosis patients?

Education & Training:

New Jersey Medical School

Newark NJ

2001

Internship and Residency in Internal Medicine

Duke University Medical Center

Durham NC

2001-2004

Clinical and Research Fellow in Infectious Diseases

Massachusetts General Hospital

Boston MA

2005-2009

Senior Fellowship in Infectious Diseases

University of Washington School of Medicine

Seattle WA

2009-2010

Honors:

Alpha Omega Alpha (AOA) Medical Honors Society, UMDNJ -New Jersey Medical School

2000

Infectious Disease Society of Washington Fellow Research Award and Presentation

2010

Chair of Medicine Scholars Award

2013

American Society of Clinical Investigation –Young Physician Scientist Award

2014

Contact

Email:

seshadri@uw.edu

Phone:

(206) 543-6709

Mailing Address:

750 Republican St.

Box 358061

Seattle, WA 98109

Research & Clinical Interests

Research Interests:

Tuberculosis
Immunology

Clinical Interests:

General medicine
General infectious diseases
Tuberculosis

Publications

PubMed:

PubMed Bibliography

Publications:

Seshadri C, Thuong NT, Yen NT, Bang ND, Chau TT, Thwaites GE, Dunstan SJ, Hawn TR. A polymorphism in human CD1A is associated with susceptibility totuberculosis. Genes Immun. 2014 Apr-May; 15(3):195-8.Epub 2014 Feb 6.
• PubMed Abstract

Seshadri C, Shenoy M, Wells RD, Hensley-McBain T, Andersen-Nissen E, McElrath MJ, Cheng TY, Moody DB, Hawn TR. Human CD1a deficiency is common and genetically regulated. J Immunol. 2013 Aug 15; 191(4):1586-93. Epub 2013 Jul 15.
• PubMed Abstract

Seshadri C, Turner MT, Lewinsohn DM, Moody DB, Van Rhijn I. Lipoproteins are major targets of the polyclonal human T cell response to Mycobacterium tuberculosis. J Immunol. 2013 Jan 1; 190(1):278-84. Epub 2012 Nov 28.
• PubMed Abstract

Kasmar AG, van Rhijn I, Cheng TY, Turner M, Seshadri C, Schiefner A, Kalathur RC, Annand JW, de Jong A, Shires J, Leon L, Brenner M, Wilson IA, Altman JD, Moody DB. CD1b tetramers bind aß T cell receptors to identify a mycobacterial glycolipid-reactive T cell repertoire in humans. J Exp Med. 2011 Aug 29; 208(9):1741-7. Epub 2011 Aug 1.
• PubMed Abstract

Drage MG, Tsai HC, Pecora ND, Cheng TY, Arida AR, Shukla S, Rojas RE, Seshadri C, Moody DB, Boom WH, Sacchettini JC, Harding CV. Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2. Nat Struct Mol Biol. 2010 Sep; 17(9):1088-95. Epub 2010 Aug 8.
• PubMed Abstract

Printer-friendly